Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |